Literature DB >> 31496596

Can Preoperative Ultrasonography and MRI Replace Sentinel Lymph Node Biopsy in Management of Axilla in Early Breast Cancer-a Prospective Study from a Tertiary Cancer Center.

Sangram K Panda1, Ashish Goel1, Vikash Nayak1, Saleem Shaik Basha1, Pankaj K Pande1, Kapil Kumar1.   

Abstract

Although SLNB is a less invasive procedure in detecting axillary lymph node metastases(ALNM) in early breast cancer; still, it carries some complications like lymphedema and in addition, performing SLNB requires surgical skills, technical knowledge, presence of facility like preoperative sentinel lymphoscintigraphy, and availability of hand-held gamma probe for intraoperative assessment. We calculated the relative diagnostic strength of preoperative axillary USG and MRI and compared with of SLNB for detection of ALNM in early breast cancer and assessed whether MRI and USG could accurately predict axillary LN status, potentially replacing SLNB. We evaluated 40 cases of clinically node-negative early breast cancer with preoperative axillary USG and MRI and subsequently subjected to SLNB. The sensitivity, specificity, PPV, NPV, and accuracy of axillary USG were 62.5%, 96.88%, 88.33%, 91.18%, and 90% respectively (p value < 0.001). The sensitivity, specificity, PPV, NPV, and accuracy of MRI in detection of ALNM were 75%, 93.75%, 75%, 93.75%, and 90% (p value < 0.001). The sensitivity, specificity, PPV, NPV, and accuracy of combined USG and MRI in detection of ALNM were 87.5%,90.63%, 70%, 96.67%, and 90% respectively (p value < 0.001), which are comparable to previous study series. The diagnostic performance of combined approach of axillary USG and MRI is promising, as the NPV of combined USG and MRI is approaching the NPV of the SLNB in detecting ALNM. Based on above findings, if axillary LNs are found nonsuspicious in preoperative axillary USG and MRI, further axillary dissection may be avoided, and if found suspicious, then ALND may be directly proceeded avoiding SLNB in between.

Entities:  

Keywords:  MR mammography; Sentinel node biopsy; USG breast

Year:  2019        PMID: 31496596      PMCID: PMC6708010          DOI: 10.1007/s13193-019-00924-7

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  25 in total

Review 1.  Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review.

Authors:  Soledad Alvarez; Enrique Añorbe; Pilar Alcorta; Fernando López; Ignacio Alonso; Julia Cortés
Journal:  AJR Am J Roentgenol       Date:  2006-05       Impact factor: 3.959

2.  Use of axillary ultrasound, ultrasound-fine needle aspiration biopsy and magnetic resonance imaging in the preoperative triage of breast cancer patients considered for sentinel node biopsy.

Authors:  Antonio García Fernández; M Fraile; N Giménez; A Reñe; M Torras; L Canales; J Torres; I Barco; S González; E Veloso; C González; L Cirera; A Pessarrodona
Journal:  Ultrasound Med Biol       Date:  2011-01       Impact factor: 2.998

3.  POSNOC: A Randomised Trial Looking at Axillary Treatment in Women with One or Two Sentinel Nodes with Macrometastases.

Authors:  A Goyal; D Dodwell
Journal:  Clin Oncol (R Coll Radiol)       Date:  2015-08-05       Impact factor: 4.126

4.  A four node axillary sampling trial on breast cancer patients.

Authors:  Kanji Tanaka; Daigo Yamamoto; Sayaka Kanematsu; Homa Okugawa; Yasuo Kamiyama
Journal:  Breast       Date:  2005-08-01       Impact factor: 4.380

Review 5.  An update on the medical management of breast cancer.

Authors:  Belinda Yeo; Nicholas C Turner; Alison Jones
Journal:  BMJ       Date:  2014-06-09

6.  The risk of nodal metastases in breast cancer patients with clinically negative lymph nodes: a population-based analysis.

Authors:  A C Voogd; J W Coebergh; O J Repelaer van Driel; R M Roumen; M W van Beek; A Vreugdenhil; M A Crommelin
Journal:  Breast Cancer Res Treat       Date:  2000-07       Impact factor: 4.872

7.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.

Authors:  Robert E Mansel; Lesley Fallowfield; Mark Kissin; Amit Goyal; Robert G Newcombe; J Michael Dixon; Constantinos Yiangou; Kieran Horgan; Nigel Bundred; Ian Monypenny; David England; Mark Sibbering; Tholkifl I Abdullah; Lester Barr; Utheshtra Chetty; Dudley H Sinnett; Anne Fleissig; Dayalan Clarke; Peter J Ell
Journal:  J Natl Cancer Inst       Date:  2006-05-03       Impact factor: 13.506

8.  Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging.

Authors:  Stephanie A Valente; Gary M Levine; Melvin J Silverstein; Jessica A Rayhanabad; Janie G Weng-Grumley; Lingyun Ji; Dennis R Holmes; Richard Sposto; Stephen F Sener
Journal:  Ann Surg Oncol       Date:  2012-01-07       Impact factor: 5.344

9.  Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND).

Authors:  Oreste Gentilini; Umberto Veronesi
Journal:  Breast       Date:  2012-07-25       Impact factor: 4.380

10.  Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.

Authors:  Y-S An; D H Lee; J-K Yoon; S J Lee; T H Kim; D K Kang; K S Kim; Y S Jung; H Yim
Journal:  Nuklearmedizin       Date:  2013-11-13       Impact factor: 1.379

View more
  1 in total

1.  Prospective comparison of CT and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results.

Authors:  Nils Martin Bruckmann; Julian Kirchner; Janna Morawitz; Lale Umutlu; Ken Herrmann; Ann-Kathrin Bittner; Oliver Hoffmann; Svjetlana Mohrmann; Marc Ingenwerth; Benedikt M Schaarschmidt; Yan Li; Andreas Stang; Gerald Antoch; Lino M Sawicki; Christian Buchbender
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.